{"name":"Denovo Biopharma LLC","slug":"denovo-biopharma-llc","ticker":"","exchange":"","domain":"denovollc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"14C-LY2140023","genericName":"14C-LY2140023","slug":"14c-ly2140023","indication":"Other","status":"phase_1"},{"name":"14C-LY404039","genericName":"14C-LY404039","slug":"14c-ly404039","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"14C-LY2140023","genericName":"14C-LY2140023","slug":"14c-ly2140023","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"14C-LY404039","genericName":"14C-LY404039","slug":"14c-ly404039","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQY0EyRFZ3NjVXbWN2Mzh2aDNJZS1GR3pmR3d4VHd1MUxMVElCb21LYjdUQjctZUcyQ1NJY1BKWldKVkpnZVRVMVhHZVRhUVViZHAyejBtMnRxSlFlV0xfaGdhVC0wd2huQi13Tk5uUGpjWGFkX1pHNGVHWDF2UnFQdUdmVF9WSHowcVlab1ZJbUxvSFBKcWc?oc=5","date":"2026-03-20","type":"pipeline","source":"openPR.com","summary":"Glioma Pipeline Expands as 180+ Pharma Companies Advance - openPR.com","headline":"Glioma Pipeline Expands as 180+ Pharma Companies Advance","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_wFBVV95cUxPTW5WNnF3QkRTRFQ0cDRJSEpKQnE4ZUJQTVdtRW42enlJLUFvdjVDVHVQM25SdDQtc1ZkbFlOWmFUS0tISFpZRTZOMmx6VTJ6Y3pReUctZmozSTEtZFFyMmZrY2ZZSy02TVNJcm9XWlpOZVg3cWpCbjRDQUxjektjeXpIU3lHQnZkSjhqMVpYOXBDQ2pkTEZOQWFJVGtmN0szU3ViUTl2eEM5M2tJcm1zZXk3LWlKOWxnZy1rZXV4X1A5WlJCZ0tKNGx1dVpKRDJQZ2l2dldqX29veDN6cEduMlNhU3NWdmxNeTRBNkEzSXVENXVlSEFqY3lITzJERzQ?oc=5","date":"2025-09-12","type":"deal","source":"Citeline News & Insights","summary":"The Rise In China Deals: How International Biopharma Is Turning To China For Innovation - Citeline News & Insights","headline":"The Rise In China Deals: How International Biopharma Is Turning To China For Innovation - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPcnNPQTBJOFhpWHNhQkJ0OUQxR1p1c0Jna1IyRWFOY24zWlh3cWI0M1NaR0tnaXRocmpJamZHZFJNWGFxWkVIYmFrb3J3T0NFN1hlV2VNTUpfY2x1ZVJBSS1tb0c4WkUwZ2c1SWFzUFBNV3lLVGVhMW41YWZnWWp4NFlsejJjWWJpLWVn?oc=5","date":"2025-06-23","type":"deal","source":"Yahoo Finance","summary":"Denovo Biopharma LLC Enters into an Exclusive Out-License Agreement with Chuang Yi Global Asset Management Co., Ltd. for Biomarker-Guided DB104 (liafensine) in Patients with Treatment-Resistant Depres","headline":"Denovo Biopharma LLC Enters into an Exclusive Out-License Agreement with Chuang Yi Global Asset Management Co., Ltd. for","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AJBVV95cUxNaGlQNjliVWkwd1ZuZF9tb3dvcW85WXBRaldaeDhIcEJEY2dGNnl2SmhXLWswUWdWS09BVzNlUGNJOU85Mlh3RW5DbHg4MTJRU2VBYTk4VzdZMVFqNkNsVmdKcUg0TkIyWFoxOWNuVVpDT2FTdER5U1k3cW9GaXo3RjE1Y19SUEpRQmd6U0xxTzAzYXF6UTF5UWlwYUF1dFMzdHo4Qk5oWFhLUjdrbnk3eVhOWW05M0tEOE1kMzJiVTV5ZnBKMms2cGJQbHVPeUNfWmxWTUotbFVMekZwVk5XRlB0N1hwYnRqQVVHUVFCMmtHWU9OVGE4VnN5Z3NGSmVJVkttaHpYYzVGckdKNkI3aVYtX3lPSVVWUklod1ZtcG5PRmI5amxnS0xjVUpOWlhPdV94TXYtTmVSVjg4TzNod0o1MDZiMTRCNV9LVjdOamRndzZ4c3ljYXRkYlBUQkFZZHZtUA?oc=5","date":"2024-05-28","type":"trial","source":"PR Newswire","summary":"Denovo Biopharma LLC to Present Positive Phase 2b ENLIGHTEN Trial Data for DGM4 Biomarker-Guided DB104 (liafensine) Treatment for Treatment ‑Resistant Depression at the ASCP 2024 Annual Meeting - PR N","headline":"Denovo Biopharma LLC to Present Positive Phase 2b ENLIGHTEN Trial Data for DGM4 Biomarker-Guided DB104 (liafensine) Trea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPMW0telVfT3puYlFST2Q3Q0ZGTW1tTUVuandxeXAwR2xfSU9kcUxTUUxGT0k0TENoRklMU3BYRFlIZnBnNmx0cG9qdlJfbnlBUTh1Tm1DM3lPdDNHYVk2TjJaRTJaMnBQV2pTZEVlUGRtSVJSQXd3V29VZEdycnh1YTZZUQ?oc=5","date":"2024-05-21","type":"pipeline","source":"San Diego Business Journal","summary":"Denovo Scores $11.8M Grant - San Diego Business Journal","headline":"Denovo Scores $11.8M Grant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNRDRlY1VoSmV6by1MY0hiUUFxWGVSb2taTXg1VEloelJhY2lGbWdGZE5vd210N2NENE12MmJzOEs2S25nd01CUktUTk4yV1locmMxeE1qX0wxWUtXYmtVVmRKX1Q5T01iVUIyYU9id1JUeVhWRF9UY2VRR0lib0Q2ZnRBZ3NFTm9Hc0IwbU9WN0MxVXpoRC1MSWNaREo5LVBHWURaVFc0a050UUpfd2h0aXRjOGdCSE1mS3JDV2ttc3FENXA0eUpFVlc0ZnlIaXZSTE9SalJVaFNWU0U2TGItVUxkMWIxOEo3S2xzdEtwSk1LQQ?oc=5","date":"2024-04-03","type":"pipeline","source":"PR Newswire","summary":"Denovo Biopharma Announces a Major Breakthrough in Treatment-Resistant Depression with Precision Medicine - PR Newswire","headline":"Denovo Biopharma Announces a Major Breakthrough in Treatment-Resistant Depression with Precision Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPZFQ3QjBUY0h3U3MtM1d4SjhJWjdhSk9BVm5kY3JTSXowOUxySGN1dEdYZEN4STdxUjEzYWt5WEhPRWFyVFhMZF9zV250bDZfV3l2MzlhLXF6ZkxDV05XdWduY1h2TTRrNENkdTlRa21jcHJIQUk4NkpQblZFRkVTZUNkMHM0bTdzZFNOOTZtcWx2dV9hcUpaTmpZRWlwTlVuUFdXMHdnOFhaQQ?oc=5","date":"2021-07-02","type":"regulatory","source":"Fierce Biotech","summary":"Lundbeck sells off flopped Alzheimer's drug as Aduhelm approval ups interest - Fierce Biotech","headline":"Lundbeck sells off flopped Alzheimer's drug as Aduhelm approval ups interest","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNRVFiV1hWc3dYVXhqcURaQm54TzFhOS1hcERYMS1oR280N0EyNnAwaU9BemRaSS1sQ1RzVlhVTTNlTEl4dVFnVXo3SWJaaXRhcm5xbTVUTmgyZWNOR0JlaXBpWWhWaFBHeFZ5RVVVcUhKSWRrcXhrR1huQnVLMmtJN0JmdDNheHJhV0h2MEpYYlN2bUNTQ3RBdk9NV0NzcGxXMk01TDJIQVQwZDI0LVhEejFqUXlRU2p6LVhoUzdpTGRhMHVTeWwxQXFHUWJlWW8?oc=5","date":"2021-07-01","type":"deal","source":"PR Newswire","summary":"Denovo Biopharma In-Licenses Late-Stage Alzheimer's Disease Asset from Lundbeck - PR Newswire","headline":"Denovo Biopharma In-Licenses Late-Stage Alzheimer's Disease Asset from Lundbeck","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOQnZUQnNxZnVtSjJaN0NEb1dCUnd2LUNTbW84NnppN3RPTnNwOFhWQmE2LS15TjNYOFFWTG9ZN0RUZWUtTnB0bXNGWXF0V3dfeW9OUUJYcW5rcjJ2aU93a1JrOXJDbXJGWGZfcVBRX3lZSWRheDU3ZVVyVi1rSHI5QWE0QllURlY4aW9JbkR5akpZa2M3SldiLXpxSHV1WUpXRjRGcnY4d21vaGcxUXRzNWxhRzJuR2FxMWh5MUF1NmFfcEI1VG5EdXlqNUhlTXVHQ0M4dlJmbnJKOHp0SDhFdkprZXdvM0k?oc=5","date":"2020-12-10","type":"deal","source":"PR Newswire","summary":"Denovo Biopharma Acquires a Novel Late-Stage Oncology Drug and Expands into Protein Therapeutics - PR Newswire","headline":"Denovo Biopharma Acquires a Novel Late-Stage Oncology Drug and Expands into Protein Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgJBVV95cUxPbXltU016SXN1RGs1MUNaUjc1SnYxMEJoWDBGWHplcEVtUldvVVJJNjBmSXJTMHpUaFF4Q0xiM0Y4T1BvNmxqRDV4c19qRk9pcVJHQldsQnlUcVdhOGphMGpRS1ZRYVZ1U2UySlBqY2FEcFAxbzhXRFhod1AxcG1ob3BId2hSMktmTGptMWs1TTZzUjRQNFdYNm9saWNEVU9EaUg0U3pXQ1RaSFBfenNoQVhRR3I0WjRXN0J3S0lSc1A2cGJ6Wi1hMGg0cXg3NFpUTDdTYTRZNnpWRlpnT0V0Z1FONHdoR29nR0hpdjBiOVc3S2lVVlpqeUliQXdRZi1aNXhWT21sUzZXZDJBblEzSkl6NTFpTWI5V3d2MmlQa0thOXFYbVR1ZXdVTlFZcllCcGhlUW13?oc=5","date":"2019-06-18","type":"pipeline","source":"PR Newswire","summary":"Denovo Biopharma Receives Global Rights to a Novel Late-Stage Drug for Alzheimer's Disease from Orion Corporation for Development as a Personalized Medicine - PR Newswire","headline":"Denovo Biopharma Receives Global Rights to a Novel Late-Stage Drug for Alzheimer's Disease from Orion Corporation for De","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOR2V4NnNZWFpEY1hjdHNwN1dCVWJpUFotU01ZNzFQRnFtbThJM2otZ1cxYTZrTlRjeTIwMnZVRmw5WDZNR0dNeU9ZbzVZZWdFYkhZbERQZmFvdVZ5WnNHcmNybHRIVHlYSVlpSmoxSlFmd2dwbkg1OWw4QmEwblN4emdxaW9sSGxRMFRyRm1BRWlaSDBmYkZwNzNwUzJwSE4yXy1LdFFoRHlvUzFlVGljMTVvMTdqYV9BNlhSOWo0YVFMUQ?oc=5","date":"2015-03-08","type":"deal","source":"Fierce Biotech","summary":"Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Lilly For Development As A Personalized Medicine - Fierce Biotech","headline":"Denovo Biopharma Licenses Late-Stage Neuroscience Drug From Lilly For Development As A Personalized Medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOc0tUcDBzWm40RHV0bzlQQmtodWNESzVfRFZlMWdNdGRJSkM3ckQ0QkVmZEQxa3F5RDlPOHRuOHUwMFdZcEJoQlU2RS1zdEFNRUJ0RV9hdC04VjJBRE9ldzJEX0JrcDVVeGRGM1VmbVgyLVRDeXRodjg4RE1YVm5abXJtVVZKelRwNmJJbjRiOHloVXM1cDdOTGk1OHdPc2Y4b1V2UVJOc1RITTcwejcyU2ZGMnVPTk5HNlE?oc=5","date":"2014-09-17","type":"deal","source":"Fierce Pharma","summary":"Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine - Fierce Pharma","headline":"Denovo Biopharma Acquires Late-Stage Oncology Drug From lilly For Development As A Personalized Medicine","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}